MBRX Stock: Moleculin Announces 100% Survival

Moleculin Biotech MBRX Stock News

Moleculin Biotech Inc (NASDAQ: MBRX) is running for the top in the market this morning, trading on gains of nearly 100% after announcing that a preclinical treatment led to a 100% survival rate in animals with metastatic osteosarcoma. Here’s what’s going on: Skip to What You Want to Read Moleculin Biotech Announces Positive Oncology Data … Read more

Moleculin Biotech (MBRX) Stock: Climbing On Coming Conference Call

Moleculin Biotech MBRX Stock News

Moleculin Biotech Inc (NASDAQ: MBRX) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it will be holding a conference call to discuss a recent discovery in the potential treatment of lung cancer. As you could imagine, the news excited investors, pushing the stock … Read more

Moleculin Biotech (MBRX) Stock: Climbing On Significant Discovery

Moleculin Biotech MBRX Stock News

Moleculin Biotech Inc (NASDAQ: MBRX) is making a run for the top in the market this morning, and for good reason. The company said that it has made a significant discovery in the breast cancer space, exciting investors and sending the stock for the top. Today, we’ll talk about: The significant discovery that was announced … Read more

Moleculin Biotech (MBRX) Stock: Gaining On Leukemia Drug Program Expansion

Moleculin Biotech MBRX Stock News

Moleculin Biotech Inc (NASDAQ: MBRX) is having a great day in the market today, and for good reason. The company announced the successful expansion of a clinical drug program. As you could imagine, the news excited investors who are pushing the stock on a run for the top. Today, we’ll talk about: The successful drug … Read more

Moleculin Biotech (MBRX) Stock: Flying On Trial Approval

Moleculin Biotech Inc (NASDAQ: MBRX) is having an overwhelingly strong start to the trading session, and for good reason. The company announced that it has received regulatory approval with regard to beginning a clinical trial in the fight against acute myeloid leukemia (AML). Of course, the news excited investors who are sending the stock on … Read more

Moleculin Biotech (MBRX) Stock: Gaining Big On Breakthrough

Moleculin Biotech Inc (NASDAQ: MBRX) is having an incredibly strong start in the market today with gains over 50%. The gains are ultimately the result of a press release that was issued this morning in which the company announced a big breakthrough in the treatment of cancer. As we would expect, the news excited investors, sending … Read more

Moleculin Biotech (MBRX) Stock: A Good Story To Tell

Moleculin Biotech Inc (NASDAQ: MBRX) Moleculin Biotech is another one of those promising small biotechs that have compiled a compelling set of clinical data and have a solid pipeline and an experienced management team focused on getting its products through trials. But, like so many of these promising companies that are on the precipice of dealing … Read more